Sycomore Asset Management Edwards Lifesciences Corp Transaction History

Sycomore Asset Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$81.41 - $94.33 $4,884 - $5,659	-60 Reduced 11.15%	478 $43,000
Q1 2023 Apr 07, 2023	SELL	$74.26 - $84.51 $30,149 - $34,311	-406 Reduced 43.01%	538 $44,000
Q4 2022 Jan 05, 2023	BUY	$68.3 - $87.44 $9,562 - $12,241	140 Added 17.41%	944 $70,000
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $30,995 - $39,015	304 Added 60.8%	804 $94,000
Q4 2021 Jan 14, 2022	BUY	$106.37 - $130.68 $53,185 - $65,340	500 New	500 $65,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Sycomore Asset Management, based on Form 13F filings with the SEC.

Stay updated on Sycomore Asset Management with notifications on news.